Trade Ideas
Actionable trade ideas with entry/stop/target and risk framing.
Cushman & Wakefield (CWK) - Buy the Ongoing Recovery: Improving Margins and Measured Deleveraging
Operational cash flow is back, margins are expanding and leverage is coming down - a tactical long with defined risk controls.
Cushman & Wakefield's latest quarters show durable top-line growth, improving operating income and a clear reduction in noncurrent liabilities. At ~ $...
Alphabet's Ironwood Moment: Betting on the Zero-Marginal-Cost Compute Flywheel
A pragmatic long trade around AI scale, cash flow conversion and margin optionality
Alphabet's scale in search, an accelerating cloud and a heavy R&D pipeline create an asymmetric setup as AI drives down marginal compute cost. With re...
Teekay Tankers: A Position Trade Built For A Cycle, Not A One-Off Spike
Buy the structural recovery in tanker economics with a disciplined entry and a tight stop - cycle exposure, modest yield, high volatility
Teekay Tankers (TNK) is set up to benefit from multi-year tanker rate improvement driven by limited fleet growth and stronger oil flows. The shares ha...
Speculative Buy: INO-3107 Readout Could Reprice Inovio (INO) — Small-Cap, Big Binary Upside
Balance-sheet stretched but market cap tiny; a positive INO-3107 catalyst and managed risk make this a high-risk, asymmetric trade.
Inovio (INO) is a highly speculative buy around $1.56. The investment case rests on an upcoming clinical/strategic catalyst tied to INO-3107 (not deta...
The Trade Desk: Growth Is Cooling, Profits Are Rising - A Tactical Long for the Profit Era
After a brutal 2025 reset, TTD shifts from hyper-growth narrative to margin and capital-return story — a buy with clear entry, stops and targets.
The Trade Desk's revenue growth has decelerated but the company is materially improving margins, generating strong operating cash flow and returning c...
Buy AZN: Oncology Engine and Pipeline Make a Convincing Case for a Breakout
A tactically sized long with clear entries, stops and staged targets—play the oncology-led rerating.
AstraZeneca's oncology franchise (~40% of revenue) and recent positive late-stage readouts support a continued rerating. The stock has moved from the ...
Alpha Pro Tech: Cheap, Cash-Generating, and Buyback-Backed — A Tactical Long
Small-cap building-supplies and PPE maker with a clean balance sheet, steady cash flow and an active buyback program — trade it as a low-volatility swing-long with defined risk.
Alpha Pro Tech (APT) is a capital-light manufacturer of building weatherization products and disposable protective apparel. The company is trading at ...
Why Garrett Motion (GTX) Deserves a 2026 Long: Cash Flowing, Cheap vs. Risky Balance Sheet
A tactical, high-conviction long with explicit entry, stops and two price targets — thesis rests on stable operating cash, EV product wins and a cheaper-than-it-looks valuation.
Garrett Motion designs turbochargers and electric-boosting systems for OEMs and aftermarket channels. Recent quarters show steady revenue around $0.9B...
Why BigBear.ai Is Now My Highest-Upside 2026 AI Bet (Despite My Earlier Skepticism)
A disciplined long: balance-sheet insurance, a small profitability inflection, and low expectations create asymmetric upside
I turned from skeptic to constructive on BigBear.ai (BBAI). Recent filings show a materially stronger balance sheet, a positive net income quarter (Q3...
Dollar General: Buy the Defensive Discount on Pullbacks — Tactical Trade Plan
Stable cash flow, modest dividend and a reasonable multiple make DG a tactical long from current levels
Dollar General (DG) looks attractive at ~ $143/share. The business remains cash generative (operating cash flow of $1.00B in the latest quarter) and c...
Buy Genmab (GMAB) on Strength of Recent Clinical Readouts — Buy on Pullback or Breakout
Clinical catalysts and corporate moves put Genmab back in growth mode; trade plan favors a risk-managed long.
Genmab's December 2025 clinical dataset (EPKINLY and epcoritamab programs) and aggressive corporate moves (Merus tender/offer activity and debt financ...
Seanergy Maritime (SHIP) - Cheap at Current Rates; Upgrade to Strong Buy
Actionable swing trade: buy the dividend-paying dry-bulk owner while the market underprices fleet cash flow optionality
Seanergy (SHIP) looks compelling at ~9.43 per share. The stock has recovered from its mid-year lows and pays meaningful cash dividends; with visible f...